The Corporate Governance Report presents the structure, rules and processes that form the basis of Lonza’s corporate governance. The Report follows the structure of the SIX Swiss Exchange’s Directive on Information relating to Corporate Governance. The principles and rules of Lonza’s corporate governance are laid down in the Lonza Articles of Association and in the Regulations Governing Internal Organization and Board Committees, including their Charters. In the implementation of its corporate governance, Lonza follows the Swiss Code of Best Practice for Corporate Governance issued by the Swiss Business Federation economiesuisse.
Sven Abend was Chief Operating Officer (COO) Specialty Ingredients from January 2016 until July 2020
Albert M. Baehny was Chief Executive Officer (CEO) ad interim from November 2019 until November 2020
In February 2021, Lonza signed an agreement to divest the Specialty Ingredients segment to Bain Capital and Cinven. The transaction is expected to close in H2 2021
Nationality: Swiss
Year of birth: 1952
Chairman of the Board of Directors of Lonza Group Ltd (since 2018), Independent member of the Board of Directors of Lonza Group Ltd (since April 2017).
On 12 November 2019, Albert M. Baehny took on the responsibilities as CEO ad interim until his successor, Pierre-Alain Ruffieux, assumed the position on 1 November 2020.
Albert M. Baehny holds a degree in biology from the University of Fribourg (CH).
Current Activities and Functions
Former Activities and Functions
Nationality: Swiss
Year of birth: 1959
Vice-Chairman of the Board of Directors of Lonza Group Ltd (since April 2020); Independent member of the Board of Directors of Lonza Group Ltd (since April 2016).
On 12 November 2019, Christoph Mäder was appointed Lead Independent Director by the Board.
Christoph Mäder holds a Master’s degree in law from the University of Basel (CH) and is admitted to the Swiss Bar.
Current Activities and Functions
Former Activities and Functions
Nationality: Swiss
Year of birth: 1950
Independent member of the Board of Directors of Lonza Group Ltd (since April 2013).
Werner Bauer holds a diploma and PhD in chemical engineering from the University of Erlangen-Nürnberg (DE). He has received several scientific honors, among others the BioAlps Award 2011 and Honorary Senator from the Technical University of Munich (DE).
Current Activities and Functions
Former Activities and Function
Nationality: Austrian
Year of birth: 1968
Independent member of the Board of Directors of Lonza Group Ltd (since April 2020).
Non-Executive Director and Corporate Finance Adviser, who brings more than 25 years of experience in the fields of manufacturing, biotech, pharmaceuticals and banking. Ms Deuring currently serves on the board of several companies including Axpo, Bilfinger and Elementis. Her Board memberships span the energy, plant engineering, chemical and biopharmaceutical sectors. She received her Master of Science in Chemistry from Université Louis Pasteur, Strasbourg in 1994. In 1996 she received her Master in Business Administration from INSEAD, Fontainebleau (FR).
Current Activities and Functions
Former Activities and Functions
Nationality: German-Brazilian
Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).
Angelica Kohlmann holds a MD and doctorate in medicine from Hamburg University (DE).
Current Activities and Functions
Former Activities and Functions
Nationality: British
Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since April 2014).
Barbara Richmond holds a first-class degree in management science from the University of Manchester Institute of Science and Technology in England. Barbara Richmond has substantial knowledge as a financial expert, demonstrated by her roles as Chief Financial Officer for various companies. She is a Fellow of the Institute of Chartered Accountants in England and Wales.
Current Activities and Functions
Former Activities and Functions
Nationality: German
Year of birth: 1958
Independent member of the Board of Directors of Lonza Group Ltd (since April 2014). Jürgen Steinemann holds a degree in Economics and Business Management from the European Business School in Wiesbaden (DE), London (UK) and Paris (FR).
Current Activities and Functions
Former Activities and Functions
Nationality: Belgian
Year of birth: 1972
Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).
Olivier Verscheure holds a PhD in computer science from the Swiss Federal Institute of Technology, Lausanne (CH) (EPFL, July 1999).
Current Activities and Functions
Former Activities and Functions
Nationality: Swiss
Year of birth: 1954
Vice-Chairman of the Board of Directors of Lonza Group Ltd (April 2014 until April 2020), Independent member of the Board of Directors of Lonza Group Ltd (March 2008 until April 2020).
Patrick Aebischer holds a doctorate in medicine from the University of Geneva (CH). He has received numerous honors, including the Robert Bing Prize of the Swiss Academy of Medicine and the Pfizer Foundation Prize for Clinical Neurosciences.
Current Activities and Functions
Former Activities and Functions
Nationality: Dutch
Year of birth: 1954
Margot Scheltema holds a doctorate in international law from the University of Amsterdam and a Master of International Affairs (MIA) from Columbia University in New York (USA). Margot Scheltema has substantial knowledge as a finance, corporate governance and risk management expert, demonstrated by her operative roles in finance and management and supervisory roles in the financial sector (bank, central bank, insurance and pension funds).
Current Activities and Functions
Former Activities and Functions
Nationality: Moroccan, Belgian, US-American
Year of birth: 1959
Independent member of the Board of Directors of Lonza Group Ltd (April 2020 until May 2020).
Dr Moncef Slaoui has extensive experience from his career with GlaxoSmithKline spanning nearly 30 years. In this time, he held a number of leadership positions, including Member of the Board of GSK PLC, Chairman of Pharmaceutical R&D, and Chairman of Global Vaccines. Currently, Dr Slaoui is partner at Medicxi, a venture capital firm specializing in seed, Series A, early stage and late stage life sciences investments. He also sits on various biotechnology companies’ boards. Dr Slaoui received his Ph.D. in Molecular Biology and Immunology from Brussels University in 1983. He later received an accelerated Master of Business Administration from IMD in Lausanne (CH) in 1998.
Current Activities and Functions
Former Activities and Functions
Information tracked until the end of the term of employment with Lonza
Nationality: Swiss
Year of birth: 1969
Chief Executive Officer (CEO) and Member of the Executive Committee (since November 2020).
Pierre-Alain Ruffieux holds a doctorate in Biotechnology and a master’s degree in Chemical Engineering and Biotechnology from the Swiss Federal Institute of Technology (EPFL), Lausanne (CH).
Former Activities and Functions
Nationality: Swiss / Mexican
Year of birth: 1962
Chief Financial Officer (CFO) and Member of the Executive Committee (since October 2016).
Rodolfo J. Savitzky holds a degree in Industrial and Systems Engineering from the Tecnológico de Monterrey (MX) and an MBA in Finance and Economics from the University of Chicago (USA).
Former Activities and Functions
Nationality: British
Year of birth: 1972
Chief Human Resources Officer (CHRO) and Member of the Executive Committee (since May 2020).
Caroline Barth holds a degree in European Business Studies from the University of Sunderland (UK) and an MBA from The Open University (BE).
Former Activities and Functions
Nationality: Swiss
Year of birth: 1966
Chief Operating Officer (COO) Pharma & Biotech Segment and Member of the Executive Committee (since March 2019).
Stefan Stoffel holds a Bachelor’s degree in engineering from Lucerne University of Applied Sciences and Arts.
Former Activities and Functions
Nationality: German
Year of birth: 1968
Chief Operating Officer (COO) Specialty Ingredients Segment (January 2016 until July 2020) and Member of the Executive Committee (July 2014 until July 2020).
Sven Abend holds a Ph.D. in chemistry from the Christian-Albrechts-Universität in Kiel and a post-doctorate from the Department of Physics & Astronomy at the University of New York in Stony Brook (USA).
Former Activities and Functions
Nationality: Swiss
Year of birth: 1952
Chairman of the Board of Directors of Lonza Group Ltd (since 2018), Independent member of the Board of Directors of Lonza Group Ltd (since April 2017).
On 12 November 2019, Albert M. Baehny took on the responsibilities as CEO ad interim until his successor, Pierre-Alain Ruffieux, assumed the position on 1 November 2020.
Albert M. Baehny holds a degree in biology from the University of Fribourg (CH).
Current Activities and Functions
Former Activities and Functions
Information tracked until the end of the term of employment with Lonza